AAAAI 2024: Avapritinib Tied to Reductions in Polypharmacy in Patients With Systemic Mastocytosis
One in five patients treated with avapritinib decreased best supportive care
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.